Skip to main content
. 2021 Apr 1;42(13):1216–1227. doi: 10.1093/eurheartj/ehab094

Figure 4.

Figure 4

Effect of dapagliflozin on cardiovascular, non-cardiovascular and undetermined causes of deaths. Main causes of cardiovascular and non-cardiovascular death are shown. Event numbers for other causes of cardiovascular or non-cardiovascular deaths were below 5 and are not reported. CI, confidence interval; MI, myocardial infarction.